Delivery Order SPE2DB22D1017-SPE2DB25FF3EG
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $1,555.93. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 7, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This delivery order represents a single transaction with a firm fixed price ceiling value of $3,111.86 and an ultimate completion date of September 18, 2025. The award was made through open competition with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Clobazam 10mg tablets in a quantity of 100 units, with a contract ceiling value of $3,111.86. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a ceiling value of $6,419.43 and an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units, with a contract ceiling value of $1,620.33. This competitively awarded, non-set-aside delivery order is structured as a firm fixed price contract with an ultimate completion date of April 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $3,401.17 and an ultimate completion date of June 2, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100-count) with a ceiling value of $3,414.22. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100 at a contract value of $3,641.99. This competitively awarded, non-set-aside delivery order represents a firm fixed price transaction with an ultimate completion date of July 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Clobazam 10 mg tablets (100 count) with a ceiling value of $4,491.92. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The order is scheduled for ultimate completion on August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,143.34 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery falls...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FF3EGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 15, 2025, for the supply of Clobazam 10 mg tablets (100-count units) with a ceiling value of $2,190.50. This firm fixed-price delivery order, which is not set-aside designated, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2025. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply relationship with DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems globally. The parent IDC vehicle enables the company to fulfill diverse pharmaceutical needs across multiple therapeutic domains, including neurological treatments such as Clobazam, supporting the Defense Health Agency and other government healthcare systems through competitive, competitively-awarded delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/15/25 |